About
Globe Mapping and Ablation System, for the diagnosis and treatment of atrial fibrillation
Areas of Focus
Categories
Uncategorized Medical Device
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
8
As Collaborator
0
Total Enrollment
1,111
By Phase
NA: 6
By Status
COMPLETED: 5RECRUITING: 3
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06973031Lead Sponsor
A Prospective Clinical Study to Evaluate the Safety and Effectiveness of Pulmonary Vein Isolation Plus Box Isolation of Fibrotic Areas With the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation
NARecruiting
115 participants
Started: Jun 10, 2025 · Completed: Jun 30, 2028
NCT05462145Lead Sponsor
Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation
NARecruiting
549 participants
Started: Mar 9, 2023 · Completed: Sep 30, 2026
NCT05164107Lead Sponsor
Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation
NARecruiting
175 participants
Started: Dec 8, 2021 · Completed: May 31, 2027
NCT04954911Lead Sponsor
Clinical Performance of the Globe® Mapping and Ablation System for the Treatment of Atrial Fibrillation
N/ACompleted
6 participants
Started: Nov 2, 2021 · Completed: May 23, 2023
NCT04486924Lead Sponsor
Performance and Safety of the Globe® Mapping and Ablation System With the GPS™ Module for the Treatment of Atrial Fibrillation
NACompleted
18 participants
Started: Apr 5, 2021 · Completed: Aug 30, 2022
Locations (1)
Headquarters
Burnaby, BC, Canada
Map
Loading map...